Skip to main content
Article
Comparative Efficacy of 177Lu and 90Y for Anti-CD20 Pretargeted Radioimmunotherapy in Murine Lymphoma Xenograft Models
PLOS ONE (2015)
  • Sofia H. L. Frost, Fred Hutchinson Cancer Research Center
  • Shani L. Frayo, Fred Hutchinson Cancer Research Center
  • Brian W. Miller, Pacific Northwest National Laboratory
  • Johnnie J. Orozco, Fred Hutchinson Cancer Research Center
  • Garrett C. Booth, Fred Hutchinson Cancer Research Center
  • Mark D. Hylarides, Fred Hutchinson Cancer Research Center
  • Yukang Lin, Fred Hutchinson Cancer Research Center
  • Damian J. Green, Fred Hutchinson Cancer Research Center
  • Ajay K. Gopal, Fred Hutchinson Cancer Research Center
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • Tom A. Bäck, University of Gothenburg
  • Darrell R. Fisher, Pacific Northwest National Laboratory
  • Oliver W. Press, Fred Hutchinson Cancer Research Center
Publication Date
March 18, 2015
DOI
10.1371/journal.pone.0120561
Citation Information
Sofia H. L. Frost, Shani L. Frayo, Brian W. Miller, Johnnie J. Orozco, et al.. "Comparative Efficacy of 177Lu and 90Y for Anti-CD20 Pretargeted Radioimmunotherapy in Murine Lymphoma Xenograft Models" PLOS ONE Vol. 10 Iss. 3 (2015)
Available at: http://works.bepress.com/john-pagel/69/